0001824893-25-000001.txt : 20250408 0001824893-25-000001.hdr.sgml : 20250408 20250408132234 ACCESSION NUMBER: 0001824893-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250408 DATE AS OF CHANGE: 20250408 EFFECTIVENESS DATE: 20250408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Surrozen, Inc./DE CENTRAL INDEX KEY: 0001824893 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 301374889 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-543181 FILM NUMBER: 25821145 BUSINESS ADDRESS: STREET 1: 171 OYSTER POINT BLVD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-475-2820 MAIL ADDRESS: STREET 1: 171 OYSTER POINT BLVD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Consonance-HFW Acquisition Corp. DATE OF NAME CHANGE: 20200915 D 1 primary_doc.xml X0708 D LIVE 0001824893 Surrozen, Inc./DE 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-489-9000 DELAWARE Consonance-HFW Acquisition Corp. Corporation true 2021 Craig Parker 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Charles Williams 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Executive Officer David J. Woodhouse, Ph.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Anna Berkenblit, M.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Eric Bjerkholt 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Christopher Chai 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Mary Haak-Frendscho, Ph.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Tim Kutzkey, Ph.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Shao-Lee Lin, M.D., Ph.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Mace Rothenberg, M.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Yang Li, Ph.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Executive Officer Biotechnology Decline to Disclose 06b false 2025-03-26 false true true true true The Company issued to investors units, each consisting of one share of common stock, or pre-funded warrant in lieu thereof, and one half of a common stock warrant. false 0 Guggenheim Securities, LLC 40638 None None 330 Madison Avenue New York NY NEW YORK 10017 All States false 174999955 76402277 98597678 false 29 4584137 0 0 false Surrozen, Inc./DE /s/ Charles O. Williams Charles O. Williams Chief Financial Officer and COO 2025-04-07